These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3409530)

  • 1. Tumour markers in the cerebrospinal fluid of patients with central nervous system metastases from extracranial malignancies.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; Hart AA; Nooyen WJ
    Clin Chim Acta; 1988 Jul; 175(2):157-66. PubMed ID: 3409530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
    van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebrospinal fluid beta 2-microglobulin: a study in controls and patients with metastatic and non-metastatic neurological diseases.
    Twijnstra A; van Zanten AP; Nooyen WJ; Hart AA; Ongerboer de Visser BW
    Eur J Cancer Clin Oncol; 1986 Apr; 22(4):387-91. PubMed ID: 3525181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid beta-glucuronidase activities in patients with central nervous system metastases.
    van Zanten AP; Twijnstra A; van Benthem V; Hart AA; Ongerboer de Visser BW
    Clin Chim Acta; 1985 Apr; 147(2):127-34. PubMed ID: 3987058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid biochemical markers of central nervous system metastases.
    Schold SC; Wasserstrom WR; Fleisher M; Schwartz MK; Posner JB
    Ann Neurol; 1980 Dec; 8(6):597-604. PubMed ID: 7212647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensitivity and specificity of single and combined tumour markers in the diagnosis of leptomeningeal metastasis from breast cancer.
    Twijnstra A; van Zanten AP; Nooyen WJ; Ongerboer de Visser BW
    J Neurol Neurosurg Psychiatry; 1986 Nov; 49(11):1246-50. PubMed ID: 3540216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue polypeptide antigen activity in cerebrospinal fluid: a marker of central nervous system metastases of breast cancer.
    Bach F; Soletormos G; Dombernowsky P
    J Natl Cancer Inst; 1991 Jun; 83(11):779-84. PubMed ID: 2041052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevation of cerebrospinal fluid soluble CD27 levels in patients with meningeal localization of lymphoid malignancies.
    Kersten MJ; Evers LM; Dellemijn PL; van den Berg H; Portegies P; Hintzen RQ; van Lier RA; von dem Borne AE; van Oers RH
    Blood; 1996 Mar; 87(5):1985-9. PubMed ID: 8634448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of central nervous system involvement in patients with leukemia or non-Hodgkin's lymphoma by immunological marker analysis of cerebrospinal fluid cells.
    Hooijkaas H; Adriaansen HJ; van Dongen JJ
    Cancer Treat Res; 1988; 38():149-71. PubMed ID: 2908594
    [No Abstract]   [Full Text] [Related]  

  • 11. Tissue polypeptide-specific antigen (TPS) concentrations in cerebrospinal fluid in patients with breast cancer metastases in the central nervous system.
    Sölétormos G; Bach F
    Clin Chem Lab Med; 2001 Feb; 39(2):170-2. PubMed ID: 11341753
    [No Abstract]   [Full Text] [Related]  

  • 12. Proteomic Biomarker Identification in Cerebrospinal Fluid for Leptomeningeal Metastases with Neurological Complications.
    Galicia N; Díez P; Dégano RM; Guest PC; Ibarrola N; Fuentes M
    Adv Exp Med Biol; 2017; 974():85-96. PubMed ID: 28353226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malignancy markers in the cerebrospinal fluid.
    Koskiniemi M
    Eur J Pediatr; 1988 Oct; 148(1):3-8. PubMed ID: 3058481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis].
    Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
    No Shinkei Geka; 1991 Dec; 19(12):1135-41. PubMed ID: 1766538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The cerebrospinal fluid concentrations of beta-glucuronidase and beta 2-microglobulin in neurological disorders].
    Oda R; Hirose G; Emori T
    No To Shinkei; 1985 Feb; 37(2):155-60. PubMed ID: 3890905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid lactate dehydrogenase activities in patients with central nervous system metastases.
    van Zanten AP; Twijnstra A; Hart AA; Ongerboer de Visser BW
    Clin Chim Acta; 1986 Dec; 161(3):259-68. PubMed ID: 3802533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LDH isoenzymes in cerebrospinal fluid in various brain tumours.
    Lampl Y; Paniri Y; Eshel Y; Sarova-Pinhas I
    J Neurol Neurosurg Psychiatry; 1990 Aug; 53(8):697-9. PubMed ID: 2213048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical relevance of locally produced carcinoembryonic antigen in cerebrospinal fluid.
    Jacobi C; Reiber H; Felgenhauer K
    J Neurol; 1986 Nov; 233(6):358-61. PubMed ID: 3806144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia.
    Weller M; Stevens A; Sommer N; Schabet M; Wiethölter H
    Acta Neurol Scand; 1992 Aug; 86(2):129-33. PubMed ID: 1414221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid cell-free tumour DNA as a liquid biopsy for primary brain tumours and central nervous system metastases.
    Seoane J; De Mattos-Arruda L; Le Rhun E; Bardelli A; Weller M
    Ann Oncol; 2019 Feb; 30(2):211-218. PubMed ID: 30576421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.